Instituto do Cancer do Estado de São Paulo
São Paulo, São Paulo
What changed
Study registered, no phase assigned: Artificial Intelligence-assisted Colonoscopy in the Detection and Characterization of Colorectal Lesions
3w agoTrial registeredJun 23, 2026Source filing (opens the source filing in a new tab)
Momentum
Momentum 70 out of 100, unchanged since the last recompute.
Accelerating: several high-weight events landed recently.
Runway (estimate)
No disclosed raise on file, so there is nothing to model from.
Stage
Grant-only
The furthest-along thing in the public record. Not a projection.
Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.
Grant to raise
Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.
- Trial
NA registered
Feb 1, 2025Colorectal Cancer (CRC), Adenomatous Polyposis, Colorectal Lesions, Colorectal Cancer · RECRUITING · sponsor: Instituto do Cancer do Estado de São Paulo · Artificial Intelligence-assisted Colonoscopy in the Detection and Characterization of Colorectal Lesions
ClinicalTrials.gov · NCT07066046 (opens the source filing in a new tab)
Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources